Resources » Investigational SPK-9001: AAV-Mediated Gene Transfer for Hemophilia B – Persistent, Stable Factor IX Activity at One Year Independent of Downstream Purification Method
LINKS
DETAILS

Year: 2018

Language: English

Author(s): Spencer Sullivan

Format: Video

Investigational SPK-9001: AAV-Mediated Gene Transfer for Hemophilia B – Persistent, Stable Factor IX Activity at One Year Independent of Downstream Purification Method

ADDITIONAL INFORMATION

In the Tuesday morning session entitled Free Papers – Gene Therapy, Spencer Sullivan presents clinical results of FIX gene transfer using in vivo recombinant AAV delivery with the novel bioengineered vector SPA-9001, discussing vector design, FIX activity attained, and safety.

RELATED RESOURCES

Documents and PDFs

What is gene therapy?

This patient handbook contains basic information about gene therapy for hemophilia. The WFH does not engage in the practice of

Read More >